Cleared Traditional

K201726 - Arterial Catheter

K201726 is an FDA 510(k) clearance for Arterial Catheter, manufactured by Haolang Medical USA Corporation. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 379-day FDA review.

K201726 · Haolang Medical USA Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2021
Decision
379d
Days
Class 2
Risk

K201726 is an FDA 510(k) clearance for the Arterial Catheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Haolang Medical USA Corporation (Bellevue, US). The FDA issued a Cleared decision on July 7, 2021 after a review of 379 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Haolang Medical USA Corporation devices

FDA 510(k) Submission Details - K201726

510(k) Number K201726 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 23, 2020
Decision Date July 07, 2021
Days to Decision 379 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
254d slower than avg
Panel avg: 125d · This submission: 379d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 619
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K201726.
WATCHMAN FXD Curve Access System
K212228 · Boston Scientific Corporation · Aug 2021
Rist 071 Radial Access Guide Catheter
K211990 · Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · Jul 2021
ReCross
K210431 · Imds Operations B.V. · Jul 2021
coraCross
K210188 · Reflow Medical · May 2021
ViperCath XC Peripheral Exchange Catheter
K211251 · Cardiovascular Systems, Inc. · May 2021
SuperCross microcatheter, SuperCross FT microcatheter, SuperCross AT microcatheter
K210647 · Vascular Solutions, LLC · Apr 2021